Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Jon C. Ogg | Feb 12, 2019 at 9:50 AM EST

Why Gilead’s Pain Is Intercept’s Gain

It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for…

Jon C. Ogg | Feb 12, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two…

Jon C. Ogg | Feb 4, 2019 at 6:23 PM EST

Why Gilead’s Disappointment Is Not Just an Earnings Story

Gilead Sciences is living up to our theory that Big Biotech is now effectively the same as Big Pharma.

Chris Lange | Feb 3, 2019 at 10:15 AM EST

Alphabet, Disney, GM, Twitter and More Major Earnings Coming This Week

24/7 Wall St. has reviewed Disney, General Motors, Twitter and some of the other key stocks reporting earnings this coming…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 28, 2019 at 8:30 AM EST

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Dec 27, 2018 at 8:25 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The December 14 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Dec 20, 2018 at 11:40 AM EST

Meet Thursday’s Biggest Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a…

Chris Lange | Dec 12, 2018 at 8:40 AM EST

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

The November 30 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Dec 10, 2018 at 8:50 AM EST

Gilead Looks to Add a New CEO

Gilead shares made a slight gain early on Monday after the firm announced that there would be a big change…

Chris Lange | Nov 28, 2018 at 8:20 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 12, 2018 at 8:50 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 26, 2018 at 11:30 AM EDT

Gilead Stumbles Despite Solid Earnings Beat

Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.

Lee Jackson | Oct 26, 2018 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James, Western Digital and More

The top analyst upgrades, downgrades and other research calls from Friday included GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James…

Chris Lange | Oct 25, 2018 at 8:20 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The October 15 short interest data have been compared with the previous report, and short interest in most of the…

1 … 13 14 15 16 17 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Why Gilead’s Pain Is Intercept’s Gain

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More

Why Gilead’s Disappointment Is Not Just an Earnings Story

Alphabet, Disney, GM, Twitter and More Major Earnings Coming This Week

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Meet Thursday’s Biggest Biotech Movers

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Gilead Looks to Add a New CEO

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Gilead Stumbles Despite Solid Earnings Beat

Top Analyst Upgrades and Downgrades: GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James, Western Digital and More

Short Sellers Hike Their Bets in Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Gilead Sciences : GILD

All Gilead Sciences Articles

Why Gilead’s Pain Is Intercept’s Gain

Top Analyst Upgrades and Downgrades: BHP, Cisco, Crown Castle, Gilead, Goldcorp, Take-Two, Varonis, Whiting Petroleum and More

Why Gilead’s Disappointment Is Not Just an Earnings Story

Alphabet, Disney, GM, Twitter and More Major Earnings Coming This Week

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Meet Thursday’s Biggest Biotech Movers

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Gilead Looks to Add a New CEO

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Gilead Stumbles Despite Solid Earnings Beat

Top Analyst Upgrades and Downgrades: GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James, Western Digital and More

Short Sellers Hike Their Bets in Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do